SC12267 (4SC-101)

SC12267 · 4SC AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SC12267 (4SC-101), covering 2011-05-18 to 2012-03-01. Get the full timeline:

Most recent: Clinical Trial Update: SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 2]